Helicos BioSciences CorporationCambridge, MA, United States (NASDAQ (GM): HLCS)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Helicos Company Description

Helicos BioSciences is in the business of developing genetic analysis technologies. Its True Single Molecule Sequencing (tSMS) platform allows for the direct analysis of DNA and RNA samples without amplification, cloning, or other time-consuming preparation techniques. The company serves the research, clinical diagnostic, and drug discovery markets and aims to provide customers with the ability to compare thousands of samples. Its HeliScope genetic analysis system can be integrated into existing laboratories and consists of a computer-controlled instrument and related supplies and reagents.

View the Comprehensive Company Description for Helicos

The Company Description provides a historical perspective of Helicos's organization from inception to current status.

Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Helicos's evolution in the marketplace.

Start your free trial today


Start Your Own Franchise Business